FVIII (low-dose PK-guided extended-half-life concentrate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FVIII (low-dose PK-guided extended-half-life concentrate), covering 2022-07-20 to 2022-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia A [Phase 4]